CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 10th, 2019 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (the “Agreement”) is entered into as of April 4, 2019 (the “Effective Date”) by and between Shionogi Inc., a Delaware corporation having its principal place of business at 300 Campus Drive, Florham Park, New Jersey (“Shionogi”), and BioDelivery Sciences International, Inc., a Delaware corporation having its principal place of business at 4131 ParkLake Avenue, Suite 225, Raleigh, NC 27612 (“BDSI”). Shionogi on the one hand and BDSI on the other hand are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDMENT 3 TO TERM LOAN AGREEMENTTerm Loan Agreement • April 10th, 2019 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
THIS AMENDMENT 3 TO TERM LOAN AGREEMENT, dated as of April 4, 2019 (this “Amendment”) is made among BioDelivery Sciences International, Inc. (“Borrower”), the Subsidiary Guarantors, CRG Servicing LLC, as administrative agent and collateral agent (in such capacity, “Administrative Agent”) and the lenders listed on the signature pages hereof under the heading “LENDERS” (each, a “Lender” and, collectively, the “Lenders”), with respect to the Loan Agreement referred to below.
